Use of instrumental variable in prescription drug research with observational data: a systematic review

Abstract Objective Instrumental variable (IV) analysis may offer a useful approach to the problem of unmeasured confounding in prescription drug research if the IV is: (1) strongly and unbiasedly associated to treatment assignment; and (2) uncorrelated with factors predicting the outcome (key assump...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical epidemiology 2011-06, Vol.64 (6), p.687-700
Hauptverfasser: Chen, Yong, Briesacher, Becky A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Objective Instrumental variable (IV) analysis may offer a useful approach to the problem of unmeasured confounding in prescription drug research if the IV is: (1) strongly and unbiasedly associated to treatment assignment; and (2) uncorrelated with factors predicting the outcome (key assumptions). Study Design and Methods We conducted a systematic review of the use of IV methods in prescription drug research to identify the major types of IVs and the evidence for meeting IV assumptions. We searched MEDLINE, OVID, PsychoInfo, EconLit, and economic databases from 1961 to 2009. Results We identified 26 studies. Most ( n = 16) were published after 2007. We identified five types of IVs: regional variation ( n = 8), facility-prescribing patterns ( n = 5), physician preference ( n = 8), patient history/financial status ( n = 3), and calendar time ( n = 4). Evidence supporting the validity of IV was inconsistent. All studies addressed the first IV assumption; however, there was no standard for demonstrating that the IV sufficiently predicted treatment assignment. For the second assumption, 23 studies provided explicit argument that IV was uncorrelated with the outcome, and 16 supported argument with empirical evidence. Conclusions Use of IV methods is increasing in prescription drug research. However, we did not find evidence of a dominant IV. Future research should develop standards for reporting the validity and strength of IV according to key assumptions.
ISSN:0895-4356
1878-5921
DOI:10.1016/j.jclinepi.2010.09.006